Related Experiment Videos
Laparoscopic staging of upper gastrointestinal malignancy.
Michael S Rodgers1, John A Windsor, Jonathan B Koea
1Department of Surgery, University of Auckland, Auckland, New Zealand. mikerodgers@optusnet.com.au
ANZ Journal of Surgery
|October 4, 2003
Summary
Laparoscopic staging (LS) is a useful tool for upper gastrointestinal malignancy, reducing non-therapeutic laparotomies. Its utility varies by tumor type, with selective application recommended.
Area of Science:
- Surgical Oncology
- Gastroenterology
- Diagnostic Imaging
Background:
- Laparoscopic staging (LS) has reduced non-curative laparotomies for upper gastrointestinal malignancy.
- Advancements in radiological staging have diminished the value of invasive staging techniques.
- This study evaluates the added benefit of LS after modern radiological staging.
Purpose of the Study:
- To prospectively assess the additional utility of laparoscopic staging (LS) in upper gastrointestinal malignancy.
- To determine the impact of LS on non-therapeutic laparotomies.
- To analyze the influence of tumor type on LS efficacy.
Main Methods:
- 106 patients with potentially curable upper gastrointestinal malignancy underwent LS post-radiological staging.
- Laparoscopic findings, outcomes at laparotomy, and complications were prospectively recorded.
- Data analysis included calculating negative likelihood ratio and non-curative laparotomy rates.
Main Results:
- LS identified incurable disease in 26% of patients.
- The non-curative laparotomy rate was 16%.
- LS was most beneficial for primary liver and biliary tract tumors; least useful for colorectal liver metastases.
Conclusions:
- LS effectively reduces non-therapeutic laparotomies but offers minimal additional benefit over laparoscopic ultrasound.
- The utility of LS is tumor-dependent, with marginal benefit for colorectal liver metastases.
- Laparoscopic staging remains valuable but requires selective application based on tumor characteristics.